Form D · Other Health Care
Hamptons Extreme, Inc.
Wuhan Province, F4 · CIK 0001435530
Offering snapshot reported Nov 30, 2009 · SEC filing
- Reported sold
- $0 Offering amount: $0
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 13, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 30, 2009 | Initial | $0 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136488
The Company issued 1,100,000 shares in exchange of all shares China Polypeptide Group held in Cantix International Ltd.
Source: Form D, filed Nov 30, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dongliang Chen | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
No. 11 Jiangda Road Jianghan Economical Development Zone
Wuhan Province, F4, 430023
Wuhan Province, F4, 430023